TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.00600nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.00900nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0130nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0160nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0220nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0230nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0290nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0320nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0360nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0400nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0420nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0470nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0490nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0520nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0550nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0620nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0650nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0650nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0720nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0720nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0770nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0870nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.0990nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.142nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.216nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.273nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.323nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.436nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.438nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.446nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.539nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.685nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
TargetGenome polyprotein [1973-2419](Hepatitis C virus genotype 1b (isolate Con1) (HCV))
Sunshine Lake Pharma
US Patent
Sunshine Lake Pharma
US Patent
Affinity DataEC50: 0.763nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 1.10nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 1.5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 2.70nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: 15nM EC50: 3.5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 8.5nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 9nMAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 11nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 12nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 12nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: <10nM EC50: 12nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair
Affinity DataIC50: 27nM EC50: 13nMpH: 7.5 T: 2°CAssay Description:Assays were performed in a 96-well streptavidin-coated Flash-Plate using enzyme, RNA substrate, and [alpha-33P]GTP/GTP with inhibitor concentration v...More data for this Ligand-Target Pair